DEKON AGR (02419) announces its performance for the mid-year of 2025, with a year-on-year increase in profit before adjustment of 250% to 1.273 billion yuan.
DeKang Agriculture and Animal Husbandry released its interim performance for the six months ending on June 30, 2025.
DEKON AGR (02419) announced its interim performance for the six-month period ending on June 30, 2025. During the reporting period, the company achieved a total operating income of 11.695 billion yuan, an increase of 24.3% year-on-year; the company's profit before fair value adjustment of biological assets was 1.273 billion yuan, an increase of 250.6% year-on-year.
DEKON AGR's overall gross profit margin increased from 12.4% in the first half of 2024 to 17.4% in the first half of 2025, mainly due to the expansion of new family farms, continuous improvement in management efficiency and production indicators, as well as a decrease in feed and raw material prices, resulting in a significant reduction in the company's production costs compared to the first half of 2024.
The announcement stated that the increase in revenue was mainly due to the increase in revenue from the pig segment. The revenue from the pig segment reached 9.879 billion yuan, a year-on-year increase of 32.6%, with pig sales volume of 5.1174 million heads, a year-on-year increase of 27.1%, and the selling price of commercial pigs was 2,032.7 yuan/head, a year-on-year increase of 3.5%. This business growth is mainly attributed to the group's advanced and sustainable independent breeding system, comprehensive precision nutrition and feed formulation technology, continuous technological empowerment, efficient team management, and relentless efforts in disease prevention and control. In the increasingly competitive background of the pig industry, the synergy of breeding technology, management practices, and disease prevention measures gives the group significant counter-cyclical capabilities.
Related Articles

800 million to 3 billion! IVD MEDICAL (01931) increases its ETH reserve quota, further upgrading the circulation infrastructure of medical innovative drugs.

LINKLOGIS-W (09959) issued a profit warning, expecting a net loss attributable to shareholders of approximately RMB 370 to 390 million for the midterm.

Amazon.com, Inc. (AMZN.US) VS Walmart Inc. (WMT.US): Who is the winner?
800 million to 3 billion! IVD MEDICAL (01931) increases its ETH reserve quota, further upgrading the circulation infrastructure of medical innovative drugs.

LINKLOGIS-W (09959) issued a profit warning, expecting a net loss attributable to shareholders of approximately RMB 370 to 390 million for the midterm.

Amazon.com, Inc. (AMZN.US) VS Walmart Inc. (WMT.US): Who is the winner?

RECOMMEND

Trump Administration Explores Government Equity Investment in Intel; Shares Soar Nearly 9%
15/08/2025

Inflation “Off the Charts”: U.S. July Producer Prices Surge 0.9% Month-on-Month, 3.3% Year-on-Year
15/08/2025

World Humanoid Robot Games Debut with Competitions in Soccer, Combat, Dance, and More
15/08/2025